Start typing to search this publication.
The BSCN Debrief logo The BSCN Debrief
Open menu
The BSCN Debrief logo

Subscribe to The BSCN Debrief

Get new posts delivered straight to your inbox.

Nasdaq Clears Canary's Staked Injective ETF for Future Listing

BSCN avatar BSCN
1 min read
Nasdaq Clears Canary's Staked Injective ETF for Future Listing

Nasdaq has cleared the Canary Staked INJ ETF for listing under the ticker INJC, according to a Form 8-A filed with the Securities and Exchange Commission. The fund, managed by Canary Capital, intends to stake at least 90 percent of its Injective token holdings and charge investors a 1.10 percent annual fee. BitGo will serve as custodian.

The approval does not permit immediate trading. The fund's registration still needs to become effective before shares can be sold to investors. If launched, the product would let traditional investors gain regulated access to INJ and staking returns without directly holding cryptocurrency or operating a wallet.

Read the full story on BSC News: Nasdaq Approves Listing of Canary Staked Injective (INJ) ETF Under Ticker INJC

Want the day's biggest crypto stories in one email each morning? Subscribe to The BSCN Debrief

Subscribe to The BSCN Debrief

The BSCN Debrief: a daily newsletter from BSC News, recapping the most important crypto stories of the past 24 hours, plus quick briefs on the day's top articles.